The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Guggulsterone Inhibits NF-κB and IκBα Kinase Activation, Suppresses Expression of Anti-apoptotic Gene Products, and Enhances Apoptosis
Open accessAbstract
Guggulsterone, derived from Commiphora mukul and used to treat obesity, diabetes, hyperlipidemia, atherosclerosis, and osteoarthritis, has been recently shown to antagonize the farnesoid X receptor and decrease the expression of bile acid-activated genes. Because activation of NF-kappaB has been closely linked with inflammatory diseases affected by guggulsterone, we postulated that it must modulate NF-kappaB activation. In the present study, we tested this hypothesis by investigating the effect of this steroid on the activation of NF-kappaB induced by inflammatory agents and carcinogens. Guggulsterone suppressed DNA binding of NF-kappaB induced by tumor necrosis factor (TNF), phorbol ester, okadaic acid, cigarette smoke condensate, hydrogen peroxide, and interleukin-1. NF-kappaB activation was not cell type-specific, because both epithelial and leukemia cells were inhibited. Guggulsterone also suppressed constitutive NF-kappaB activation expressed in most tumor cells. Through inhibition of IkappaB kinase activation, this steroid blocked IkappaBalpha phosphorylation and degradation, thus suppressing p65 phosphorylation and nuclear translocation. NF-kappaB-dependent reporter gene transcription induced by TNF, TNFR1, TRADD, TRAF2, NIK, and IKK was also blocked by guggulsterone but without affecting p65-mediated gene transcription. In addition, guggulsterone decreased the expression of gene products involved in anti-apoptosis (IAP1, xIAP, Bfl-1/A1, Bcl-2, cFLIP, and survivin), proliferation (cyclin D1 and c-Myc), and metastasis (MMP-9, COX-2, and VEGF); this correlated with enhancement of apoptosis induced by TNF and chemotherapeutic agents. Overall, our results indicate that guggulsterone suppresses NF-kappaB and NF-kappaB-regulated gene products, which may explain its anti-inflammatory activities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Natural products as sources of new drugs over the period 1981–2002
Newman, D. J., Cragg, G. M., & Snader, K. M. (2003) · Journal of Natural Products · doi:10.1021/np030096l · Cited by 3,082
Signalling pathways of the TNF superfamily: a double-edged sword
Aggarwal, B. B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1184 · Cited by 2,793
Self-citationTNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
Wang, C.-Y., Mayo, M. W., & Baldwin, A. S. (1996) · Science · doi:10.1126/science.274.5288.784 · Cited by 2,617
Suppression of TNF-α-Induced Apoptosis by NF-κB
Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., & Verma, I. M. (1996) · Science · doi:10.1126/science.274.5288.787 · Cited by 2,581
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z.-W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc780 · Cited by 2,478
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390
Hsu, H., Shu, H.-B., Pan, M.-G., & Goeddel, D. V. (1996) · Cell · doi:10.1016/s0092-8674(00)80984-8 · Cited by 1,998
Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884
NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1
Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5785 · Cited by 1,312
Zhong, H., Voll, R. E., & Ghosh, S. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80066-0 · Cited by 1,210
Natarajan, K., Singh, S., Burke, T. R., Grunberger, D., & Aggarwal, B. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9090 · Cited by 1,139
Self-citationHealth-promoting properties of common herbs
Craig, W. J. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/70.3.491s · Cited by 1,095
Chu, Z.-L., McKinsey, T. A., Liu, L., Gentry, J. J., Malim, M. H., & Ballard, D. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10057 · Cited by 872
Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.
Brand, K., Page, S., Rogler, G., Bartsch, A., Brandl, R., Knuechel, R., Page, M., Kaltschmidt, C., Baeuerle, P. A., & Neumeier, D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118598 · Cited by 798
Zong, W.-X., Edelstein, L. C., Chen, C., Bash, J., & Gelinas, C. (1999) · Genes & Development · doi:10.1101/gad.13.4.382 · Cited by 720
Bharti, A. C., Donato, N., Singh, S., & Aggarwal, B. B. (2003) · Blood · doi:10.1182/blood-2002-05-1320 · Cited by 685
Self-citationYamamoto, K., Arakawa, T., Ueda, N., & Yamamoto, S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.52.31315 · Cited by 647
Stehlik, C., de Martin, R., Kumabashiri, I., Schmid, J. A., Binder, B. R., & Lipp, J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.1.211 · Cited by 635
NF-κB Inducers Upregulate cFLIP, a Cycloheximide-Sensitive Inhibitor of Death Receptor Signaling
Kreuz, S., Siegmund, D., Scheurich, P., & Wajant, H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.12.3964-3973.2001 · Cited by 583
A Natural Product That Lowers Cholesterol As an Antagonist Ligand for FXR
Urizar, N. L., Liverman, A. B., Dodds, D. T., Silva, F. V., Ordentlich, P., Yan, Y., Gonzalez, F. J., Heyman, R. A., Mangelsdorf, D. J., & Moore, D. D. (2002) · Science · doi:10.1126/science.1072891 · Cited by 549
Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer
Catz, S. D., & Johnson, J. L. (2001) · Oncogene · doi:10.1038/sj.onc.1204926 · Cited by 538
Miagkov, A. V., Kovalenko, D. V., Brown, C. E., Didsbury, J. R., Cogswell, J. P., Stimpson, S. A., Baldwin, A. S., & Makarov, S. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13859 · Cited by 467
Nuclear transcription factor-κB as a target for cancer drug development
Garg, A., & Aggarwal, B. (2002) · Leukemia · doi:10.1038/sj.leu.2402482 · Cited by 441
Self-citationShishodia, S., Majumdar, S., Banerjee, S., & Aggarwal, B. B. (2003) · PubMed · Cited by 426
Self-citationGrumont, R. J., Rourke, I. J., & Gerondakis, S. (1999) · Genes & Development · doi:10.1101/gad.13.4.400 · Cited by 403
Huang, S., Robinson, J. B., DeGuzman, A., Bucana, C. D., & Fidler, I. J. (2000) · PubMed · Cited by 369
Role of the NF-kB Pathway in the Pathogenesis of Human Disease States
Yamamoto, Y., & Gaynor, R. (2001) · Current Molecular Medicine · doi:10.2174/1566524013363816 · Cited by 329
CRAIG, W. J. (1997) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(97)00765-7 · Cited by 318
Finco, T. S., Beg, A. A., & Baldwin, A. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.11884 · Cited by 299
Giri, D. K., & Aggarwal, B. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.14008 · Cited by 299
Self-citationEmmerich, F., Meiser, M., Hummel, M., Demel, G., Foss, H.-D., Jundt, F., Mathas, S., Krappmann, D., Scheidereit, C., Stein, H., et al. (1999) · Blood · doi:10.1182/blood.v94.9.3129 · Cited by 261
Cui, J., Huang, L., Zhao, A., Lew, J.-L., Yu, J., Sahoo, S., Meinke, P. T., Royo, I., Peláez, F., & Wright, S. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209323200 · Cited by 246
G UGULIPID: A Natural Cholesterol-Lowering Agent
Urizar, N. L., & Moore, D. D. (2003) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.23.011702.073102 · Cited by 233
Miyamoto, S., Maki, M., Schmitt, M. J., Hatanaka, M., & Verma, I. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12740 · Cited by 206
The Hypolipidemic Natural Product Guggulsterone Acts as an Antagonist of the Bile Acid Receptor
Wu, J. (2002) · Molecular Endocrinology · doi:10.1210/me.16.7.1590 · Cited by 196
Methotrexate Suppresses NF-κB Activation Through Inhibition of IκBα Phosphorylation and Degradation
Majumdar, S., & Aggarwal, B. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2911 · Cited by 192
Self-citationEstève, P. O., Chicoine, É., Robledo, O., Aoudjit, F., Descoteaux, A., Potworowski, E. F., & St-Pierre, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108600200 · Cited by 187
You, M., Ku, P.-T., Hrdličková, R., & Bose, H. R. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.12.7328 · Cited by 176
[53] Assay for redox-sensitive transcription factor
Chaturvedi, M. M., Mukhopadhyay, A., & Aggarwal, B. B. (2000) · Methods in Enzymology · doi:10.1016/s0076-6879(00)19055-x · Cited by 174
Self-citationMiyamoto, S., Chiao, P. J., & Verma, I. M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.5.3276 · Cited by 171
Schwenzer, R., Siemienski, K., Liptay, S., Schubert, G., Peters, N., Scheurich, P., Schmid, R. M., & Wajant, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19368 · Cited by 167
Nasuhara, Y., Adcock, I. M., Catley, M., Barnes, P. J., & Newton, R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19965 · Cited by 162
The nuclear factor‐κB/inhibitor of kappa B autoregulatory system and atherosclerosis
Thurberg, B. L., & Collins, T. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199810000-00002 · Cited by 154
Bonizzi, G., Piette, J. G., Merville, M. P., & Bours, V. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.11.5264 · Cited by 142
Mechanisms by which IκB proteins control NF-κB activity
Simeonidis, S., Stauber, D. J., Chen, G., Hendrickson, W. A., & Thanos, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.49 · Cited by 137
Nuclear transcription factor NF-kappa B: role in biology and medicine.
Aggarwal, B. B., Takada, Y., Shishodia, S., Gutierrez‐Barrera, A. M., Oommen, O. V., Ichikawa, H., Baba, Y., & Kumar, A. (2004) · PubMed · Cited by 134
Self-citationMahon, T., & O'Neill, L. A. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.48.28557 · Cited by 117
Takada, Y., Khuri, F. R., & Aggarwal, B. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400963200 · Cited by 113
Self-citationZhu, L., Fukuda, S., Cordis, G. A., Das, D. K., & Maulik, N. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03084-8 · Cited by 108
The effectiveness of Commiphora mukul for osteoarthritis of the knee: an outcomes study.
Singh, B. B., Mishra, L. C., Vinjamury, S. P., Aquilina, N., Singh, V. J., & Shepard, N. (2003) · PubMed · Cited by 104
Manna, S. K., Mukhopadhyay, A., & Aggarwal, B. B. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.9.4927 · Cited by 97
Self-citationEstrov, Z. E., Manna, S. K., Harris, D., Van, Q., Estey, E. H., Kantarjian, H. M., Talpaz, M., & Aggarwal, B. B. (1999) · Blood · doi:10.1182/blood.v94.8.2844.420k43_2844_2853 · Cited by 77
Self-citationGuggulsterone: an old approach to a new problem
Sinal, C. J., & Gonzalez, F. J. (2002) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(02)00640-9 · Cited by 75
NF-κB and bone: The breaking point
Abu‐Amer, Y., & Tondravi, M. M. (1997) · Nature Medicine · doi:10.1038/nm1197-1189 · Cited by 47
Activation of kappa B-specific proteins by estradiol.
Shyamala, G., & Guiot, M. C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10628 · Cited by 31
Wittekindt, N. E. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.3.800 · Cited by 20
Cited by
Molecular targets of dietary agents for prevention and therapy of cancer
Aggarwal, B. B., & Shishodia, S. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.02.009 · Cited by 1,754
Self-citationGupta, S. C., Kim, J. H., Prasad, S., & Aggarwal, B. B. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9235-2 · Cited by 806
Self-citationAggarwal, B. B., Vijayalekshmi, R. V., & Sung, B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0149 · Cited by 795
Self-citationNuclear factor-κB inhibitors as sensitizers to anticancer drugs
Nakanishi, C., & Toi, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1588 · Cited by 724
Life and death in peripheral T cells
Krammer, P. H., Arnold, R., & Lavrik, I. N. (2007) · Nature Reviews Immunology · doi:10.1038/nri2115 · Cited by 653
Metadata
- Authors
- Shishodia, S., & Aggarwal, B. B.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-11
- Volume
- 279
- Issue
- 45
- Pages
- 47148-47158
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1970974410
- Cited by
- 259
- References
- 59
- FWCI
- 6.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.